Skip to main content
Back to News
HOYA Lab secured seed funding and TIPS selection to scale its AI-powered crAIspr platform, addressin...
Funding
1 min read
KR

HOYA Lab secured seed funding and TIPS selection to scale its AI-powered crAIspr platform, addressin...

The AMW Read

The article updates the player map for Vertical AI-Bio with a seed funding announcement for HOYA Lab, though it falls below the cross.§D threshold.
NoveltySignificance
Healthcare & Bio · Player Map
HOYA Lab
HOYA Lab

AI in Biotech / Drug Discovery

View Company Profile

HOYA Lab secured seed funding and TIPS selection to scale its AI-powered crAIspr platform, addressing the critical off-target problem in gene editing. By using AI to redesign guide RNA, the startup aims to eliminate unintended genetic modifications that hinder CRISPR therapy approvals. The technology is currently undergoing credibility verification for 4 rare diseases with international institutions. This systematic shift moves biotechnology from experimental discovery to a precise engineering discipline. 🧬 #AI #Biotech #CRISPR #GeneEditing #HealthTech #HOYALab #SeedFunding

How This Connects

Based on Healthcare & Bio · Player Map

  1. 4d agoInnovaccer acquires CaduceusHealth to expand AI-led revenue cycle managementInnovaccer
  2. 1w agoIsomorphic Labs raises $2.1B led by Thrive Capital in largest AI drug-discovery roundIsomorphic Labs
  3. 3w agoOpenAI model outperforms doctors in ER diagnoses, achieving 67% accuracy vs 55%OpenAI
  4. 1mo agoOpenAI Launches GPT-Rosalind, a Specialized Frontier Model for Life Sciences Research and Drug DiscoveryOpenAI
  5. 4mo agoHOYA Lab secured seed funding and TIPS selection to scale its AI-powered crAIspr platform, addressin... · THIS ARTICLE

More news from HOYA Lab

Stay updated with the latest news and announcements from HOYA Lab.

View all HOYA Lab news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard